ASX:MDC Medlab Clinical (MDC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Medlab Clinical Stock (ASX:MDC) 30 days 90 days 365 days Advanced Chart Get Medlab Clinical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume36,677 shsAverage VolumeN/AMarket CapitalizationA$15.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery. In addition, it offers virtual clinic services. The company was founded in 2012 and is headquartered in Botany, Australia. Read More Receive MDC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medlab Clinical and its competitors with MarketBeat's FREE daily newsletter. Email Address MDC Stock News HeadlinesMedlab Clinical to be Delisted from ASXFebruary 27, 2025 | tipranks.comMedlab Clinical Reports Q2 2025 Financials Amidst Strategic ChangesFebruary 2, 2025 | tipranks.comI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.July 28 at 2:00 AM | Timothy Sykes (Ad)Medlab Clinical Faces Steep Revenue Decline and LossNovember 3, 2024 | markets.businessinsider.comChild Care on College Campuses: What to KnowOctober 24, 2024 | usnews.comMedlab West Africa - the Biggest Medical Lab Event in the Region Returns to LagosApril 16, 2024 | msn.comClinical Laboratory Technician SalaryMay 20, 2023 | money.usnews.comHealthKick Podcast: Aussie Bio Tech Medlab is confident in highly anticipated Phase III trialFebruary 13, 2023 | msn.comSee More Headlines MDC Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Medlab Clinical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medlab Clinical investors own include Magellan Financial Group (MFG), iSignthis (ISX), FBR (FBR), Embark Early Education (EVO), Dacian Gold (DCN), Constellation Technologies (CT1) and Bod Australia (BDA). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryConstruction Current SymbolASX:MDC CIKN/A Webwww.medlab.co Phone61 2 8188 0311FaxN/AEmployees1,640Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($547.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$3.94 million Net Margins-1,351.41% Pretax MarginN/A Return on Equity12,575.02% Return on Assets-79.67% Debt Debt-to-Equity RatioN/A Current Ratio0.35 Quick Ratio3.71 Sales & Book Value Annual Sales-A$1.47 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow5.12 Book ValueA($0.31) per share Price / BookN/AMiscellaneous Outstanding Shares2,280,000Free FloatN/AMarket CapA$15.07 million OptionableNot Optionable Beta0.89 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (ASX:MDC) was last updated on 7/28/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop 10 Green Zone Stocks to Buy NowOthers have paid $2,000 for access to stock picks like these—this weekend, you can get them free. Using a p...TradeSmith | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medlab Clinical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Medlab Clinical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
